Dear BCG Clients and Friends
After more than 20 years of service to the Food and Drug Administration, I officially begin my new career at Biologics Consulting Group as the new President and Chief Executive Officer. I am pleased to be leading a tremendously talented staff at BCG that is thoroughly knowledgeable of the FDA regulations, and the scientific and clinical evaluation of complex biologicals, pharmaceuticals, devices, and combination products. Our strong track record of advising the regulated industry to facilitate entry of safe and effective products into the market place exemplifies the culture of excellence that Dr. Kenimer has built at BCG. I would like to take this opportunity to assure you that I will continue in that same tradition, expanding the horizons of the company far across the globe, and into scientific areas that will lead to new products that will advance global public health. I enthusiastically look forward to working with all of you.
Norman W. Baylor, Ph.D.
